Theravance Biopharma Inc (NASDAQ: TBPH) Could Be Viewed Differently By Investors Because Of These Numbers

Bethany Hill

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Theravance Biopharma Inc is $949.10M. A total of 0.25 million shares were traded on the day, compared to an average of 454.24K shares.

In the most recent transaction, Farnum Rhonda sold 31,067 shares of TBPH for 18.75 per share on Dec 03 ’25. After the transaction, the SVP, COMM & MEDICAL AFFAIRS now owns 277,695 company shares. In a previous transaction on Dec 03 ’25, RHONDA FARNUM bought 31,067 shares at 18.75 per share.

Among the insiders who bought shares, ERAN BROSHY acquired of 29,501 shares on Nov 26 ’25 at a per-share price of $20.00. In another insider transaction, ERAN BROSHY bought 45,000 shares at $17.98 per share on Nov 11 ’25.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, TBPH has a high of $20.33 and a low of $7.90.

As of this writing, TBPH has an earnings estimate of $0.32 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of $0.97 per share and a lower estimate of $0.0. The company reported an EPS of -$0.05 in the last quarter

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TBPH’s latest balance sheet shows that the firm has $173.47M in Cash & Short Term Investments as of fiscal 2021. There were $669.52M in debt and $58.59M in liabilities at the time. Its Book Value Per Share was $4.59, while its Total Shareholder’s Equity was -$338.57M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TBPH is Buy with a score of 4.25.

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.